Healthcare & Pharmaceutics

123 ABA Journal Healthcare & Pharmaceutics articles.

Afternoon Briefs: Jim Bakker warned about COVID-19 claims; Reed Smith widow loses in 7th Circuit

Televangelist told to stop peddling COVID-19 elixir

Two state attorneys general and two federal agencies are trying to stop televangelist Jim Bakker from peddling a supplement called Silver Solution as…

Letter from 50 in-house counsels seeks change in expert testimony standards
Top legal officers from 50 major corporations sent a letter Monday requesting more rigorous scrutiny of expert testimony by the federal court system.
‘Bluff City Law’ takes on the ‘American epidemic’ of opioid abuse

One of my best friends growing up in Western Oklahoma recently accomplished his first full year of sobriety. We had kept in sporadic contact over the last decade or two,…

Do courts lack info about medication-assisted treatment as an option for defendants with opioid addiction?

Judges aren’t doctors, so should they make decisions on whether medication-assisted treatment is appropriate for defendants addicted to opioids? Whether a defendant can be on probation or in drug court while receiving medication-assisted treatment can differ by judge, including those in the same jurisdiction.

ABA amicus brief urges SCOTUS to follow precedent in Louisiana abortion case
The ABA filed an amicus brief with the U.S. Supreme Court on Monday that urges the justices to reverse an appellate decision upholding a Louisiana law that requires physicians who perform abortions to have admitting privileges at a local hospital.
Judge accused of ‘partisan glee’ after $8B verdict says high-five allegations were fabricated
A Philadelphia judge accused of showing “partisan glee” and high-fiving jurors after they awarded $8 billion in a Risperdal case denied the allegation Wednesday and focused on the lawyers who made the accusation.
Government fights health care fraud with aid of data analytics
The government is using data analytics to spot trends in Medicare and Medicaid billing patterns that point to possible health care fraud.
Motion accuses judge of ‘partisan glee’ after $8B Risperdal verdict
A Philadelphia judge is accused of showing “partisan glee” after jurors awarded $8 billion in punitive damages in a case brought by a man who contended his childhood use of the drug Risperdal had caused him to grow breasts.
4 drug companies agree to $260M opioid settlement with 2 Ohio counties
Four drug companies have agreed to a $260 million opioid settlement with two Ohio counties—Cuyahoga and Summit counties—that contended that the companies misled the public in their opioid marketing and created a public nuisance that endangered health.
Oops! Judge mistakenly added three zeroes to part of opioid award
An Oklahoma judge who ordered Johnson & Johnson to pay $572 million for its role in the state’s opioid epidemic admitted in court on Tuesday that he made a $107 million math error.
Afternoon Briefs: Arrests for low-level crimes plummet; inmate complains about commissary-money restitution

Arrests for low-level crimes plummet in some cities and states

In some cities and states, arrests are plummeting for minor crimes such as disorderly conduct, loitering, prostitution and driving violations.…

Afternoon Briefs: Jurors award $8B in Rispderdal case; most minority partners have nonequity status

Jurors award $8B in punitive damages in Risperdal case

Jurors in Philadelphia found Johnson & Johnson liable for $8 billion in punitive damages Tuesday in a case brought by a…

Afternoon Briefs: Justice for bilked law firms; conviction upheld for driving lawn mower while drunk

Belgian man to plead guilty in scheme to bilk US law firms and charities

Belgian national Aref Said has notified a Massachusetts federal court that he plans to plead guilty…

$572M verdict against Johnson & Johnson in opioid suit is based on Oklahoma’s unusual public nuisance law
An Oklahoma judge ruled Monday that Johnson & Johnson is liable for $572 million for the public nuisance it created when it engaged in a marketing campaign that promoted opioid use.
Federal judge blocks HHS rule requiring drugmakers to disclose prices in TV ads
A federal judge in Washington, D.C., has vacated an agency rule that required drugmakers to disclose the list price of prescriptions in TV advertising.

Read more ...




Web First
Attorneys and advocacy groups adapt for domestic violence survivors amid COVID-19 pandemic
Original reporting ...
Topics: Career & Practice
Judge accused of ordering handcuffing, jailing of litigants should be removed, commission says
Complete list of topics ...


Your Voice
Law firms are making the same mistakes with women and millennials, lawyer says
Articles and commentary ...
Podcasts
What should you read about COVID-19? We asked an epidemiologist
More podcasts ...